H3K9 demethylase KDM3A potentiates interferon signaling and macrophage-driven inflammation in atherosclerosis
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Together, these findings establish KDM3A as an epigenetic regulator that sustains IFN-driven macrophage activation and promotes progression of atherosclerosis, nominating KDM3A as a potential target for selectively modulating IFN-dependent inflammation.
Appeared: Sunday, November 15. Science Advances. Peer-reviewed journal.